Pfizer and BioNTech Apply for COVID-19 Vaccine

Read Time: 43 Second The American company Pfizer and Germany’s BioNTech have filed a request with the Food and Drug Administration (FDA) for emergency use in the United States of their COVID-19 coronavirus vaccine. Emergency use involves starting to use the drug before completing all checks on its effect on the body. “Pfizer and BioNTech have submitted an emergency request for our COVID-19 vaccine to the FDA,” Pfizer reports on Twitter. It may take several weeks for your request to be processed. BioNTech and Pfizer previously reported that their vaccine is estimated to be 95% effective. It was noted that the effectiveness of the vaccine is the same for all ages, races and nationalities. Pharmaceutical companies are considering the possibility of filing an application for registration of the drug in Russia. For more information about the vaccine, see Kommersant’s article “Pfizer is Breaking into the Russian Market”. Happy 0 0 % Sad 0 0 % Excited 0 0 % Sleppy 0 0 % Angry 0 0 % Surprise 0 0 % Сообщение Pfizer and BioNTech Apply for COVID-19 Vaccine появились сначала на supercar.ru .